| RS1301197571 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1301198698 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS1301200599 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS1301223664 |
ABCA3
|
Health Risk |
Likely pathogenic |
Interstitial lung disease due to ABCA3 deficiency, Interstitial lung disease due to ABCA3 deficiency |
| RS1301227852 |
BSND
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1301228529 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1301235105 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
7 conditions, 7 conditions |
| RS1301268055 |
PLOD1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS1301275168 |
NEB
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita 6, Arthrogryposis multiplex congenita 6 |
| RS1301279979 |
DNM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate B, Inborn genetic diseases |
| RS1301292668 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS1301294410 |
AXIN2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1301322622 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, EP300-related disorder |
| RS1301328139 |
ZNF292
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, Intellectual disability |
| RS1301330402 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1301344134 |
ELP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Medulloblastoma, Familial dysautonomia |
| RS1301351856 |
SERPINC1
|
Health Risk |
Pathogenic |
Hereditary antithrombin deficiency, Hereditary antithrombin deficiency |
| RS1301378192 |
KIAA0586
|
Health Risk |
Pathogenic |
Joubert syndrome 23, Short-rib thoracic dysplasia 14 with polydactyly |
| RS1301394543 |
MYO15A
|
Health Risk |
Pathogenic |
— |
| RS1301396112 |
BEST1
|
Health Risk |
Likely pathogenic |
— |
| RS1301397800 |
FKRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2I |
| RS1301400509 |
PRRT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS1301441435 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1301458707 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypercholesterolemia |
| RS1301470194 |
EYS
|
Health Risk |
Likely pathogenic |
— |
| RS1301484227 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS1301501264 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1301516107 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome 1 |
| RS1301522020 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency, Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency |
| RS1301524707 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1301539761 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Inborn genetic diseases |
| RS1301544231 |
CDKN1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Beckwith-Wiedemann syndrome, Inborn genetic diseases |
| RS1301547272 |
PTCD3
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation deficiency 51, Combined oxidative phosphorylation deficiency 51 |
| RS1301584371 |
COL6A3
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1301600876 |
F8
|
Health Risk |
Likely pathogenic |
F8-related disorder, F8-related disorder |
| RS1301613270 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia type I, Citrullinemia |
| RS1301615993 |
KARS1
|
Health Risk |
Likely pathogenic |
— |
| RS1301618072 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1301632648 |
CSNK2A1
|
Health Risk |
Pathogenic |
Okur-Chung neurodevelopmental syndrome, Okur-Chung neurodevelopmental syndrome |
| RS1301635320 |
SOD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1301635888 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS1301641750 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type B |
| RS1301652826 |
PCSK1
|
Health Risk |
Likely pathogenic |
Obesity due to prohormone convertase I deficiency, Obesity due to prohormone convertase I deficiency |
| RS1301659851 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1301664794 |
MAPKBP1
|
Health Risk |
Likely pathogenic |
— |
| RS1301666663 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1301696262 |
COL4A3
|
Health Risk |
Likely pathogenic |
COL4A3-related disorder, COL4A3-related disorder |
| RS1301700806 |
TMPRSS3
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 8, Autosomal recessive nonsyndromic hearing loss 8 |
| RS1301704156 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS1301705612 |
NEK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Type IV short rib polydactyly syndrome, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS1301706601 |
LOXHD1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS1301718118 |
DUOX2
|
Health Risk |
Pathogenic |
— |
| RS1301743166 |
GNPTAB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS1301750241 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1301751251 |
BLM
|
Health Risk |
Pathogenic/Likely pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1301762186 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1301770111 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1301795658 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1301816028 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Intrauterine growth retardation |
| RS1301819180 |
FANCD2
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group D2, Fanconi anemia complementation group D2 |
| RS1301821497 |
ALDH5A1
|
Health Risk |
Pathogenic |
Succinate-semialdehyde dehydrogenase deficiency, Inborn genetic diseases |
| RS1301842578 |
LRPPRC
|
Health Risk |
Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS1301849220 |
EGLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Erythrocytosis, familial |
| RS1301850403 |
GNPTG
|
Health Risk |
Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS1301852124 |
NEU1
|
Health Risk |
Pathogenic |
Sialidosis type 2, Sialidosis type 2 |
| RS1301855639 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1301870356 |
CABP2
|
Health Risk |
Likely pathogenic |
— |
| RS1301870550 |
CYP27A1
|
Health Risk |
Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS1301873688 |
DHCR7
|
Health Risk |
Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS1301876154 |
SMARCAL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1301895052 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS1301895668 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1301901369 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1301902450 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1301904623 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1301915378 |
MPDZ
|
Health Risk |
Likely pathogenic |
— |
| RS1301940016 |
DPAGT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 13, DPAGT1-congenital disorder of glycosylation |
| RS1301940236 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1301948344 |
GARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2 |
| RS1301955422 |
MMP13
|
Health Risk |
Likely pathogenic |
Spondyloepimetaphyseal dysplasia, Missouri type |
| RS1301956720 |
NBN
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly, normal intelligence and immunodeficiency |
| RS13019803 |
IL1R1
|
Health Risk |
association |
Ascending aortic dissection, Ascending aortic dissection |
| RS1301982277 |
LPIN1
|
Health Risk |
Likely pathogenic |
— |
| RS1301983423 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS1301992983 |
SLC2A10
|
Health Risk |
Conflicting classifications of pathogenicity |
Arterial tortuosity syndrome, Arterial tortuosity syndrome |
| RS1302011604 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1302020618 |
UNG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 5, Hyper-IgM syndrome type 5 |
| RS1302034044 |
SZT2
|
Health Risk |
Pathogenic |
See cases, Developmental and epileptic encephalopathy |
| RS1302048506 |
HCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Sick sinus syndrome 2, autosomal dominant |
| RS1302054606 |
PHGDH
|
Health Risk |
Likely pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS1302055573 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1302074641 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1302075903 |
TMEM107
|
Health Risk |
Pathogenic |
— |
| RS1302076437 |
KISS1R
|
Health Risk |
Likely pathogenic |
Pituitary stalk interruption syndrome, Pituitary stalk interruption syndrome |
| RS1302083447 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1302089144 |
PROS1
|
Health Risk |
Pathogenic |
Protein S deficiency disease, Protein S deficiency disease |
| RS1302101551 |
MMP9
|
Health Risk |
Pathogenic |
Metaphyseal anadysplasia 2, Metaphyseal anadysplasia 2 |
| RS1302114356 |
ELP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial dysautonomia, Medulloblastoma |
| RS1302123106 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS1302125467 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |